Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Context Therapeutics (CNTX) posted Return on Capital Employed [ROCE] of -128.58% for Q3 2026, down 89.43 percentage points from -39.15% a year earlier and down 19.36 percentage points from the prior quarter.

Analysis

Context Therapeutics (CNTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Context Therapeutics' Return on Capital Employed [ROCE] came in at -52.73%, up 2.33 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -6.67 percentage points (FY2021 to FY2025).
  • In prior years, Context Therapeutics' Return on Capital Employed [ROCE] was -55.06% in FY2024 (+54.80 pp), -109.86% in FY2023 (-72.73 pp), -37.13% in FY2022 (+8.93 pp) and -46.06% in FY2021.
  • The Q3 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last six quarters, with an average year-over-year change of +7.98 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 169.26 percentage points; the weakest was Q1 2024, with a drop of 144.40 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -109.22% (Q2 2026), -76.16% (Q1 2026) and -60.30% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -5,780.97%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 35.41%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 17.52%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 21.60%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 4.65%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -6.15%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -128.58%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -128.58%
Jun 30, 2026 -109.22%
Mar 31, 2026 -76.16%
Dec 31, 2025 -60.30%
Sep 30, 2025 -39.15%
Jun 30, 2025 -44.79%
Mar 31, 2025 -33.78%
Dec 31, 2024 -33.44%
Sep 30, 2024 -35.30%
Jun 30, 2024 -36.23%
Mar 31, 2024 -203.03%
Dec 31, 2023 -163.51%
Sep 30, 2023 -106.02%
Jun 30, 2023 -76.18%
Mar 31, 2023 -58.63%
Dec 31, 2022 -41.78%
Sep 30, 2022 -37.05%
Jun 30, 2022 -28.28%
Mar 31, 2022 -27.60%
Dec 31, 2021 -44.32%
API Access

Context Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CNTX&period=max&api_key=YOUR_API_KEY